Cite

    Kiyoshi Okazuka et al.. “The efficacy and safety of modified bortezomib‐lenalidomide‐dexamethasone in transplant‐eligible patients with newly diagnosed multiple myeloma.” European journal of haematology, vol. 104, 2020, pp. 110–115. http://access.bl.uk/ark:/81055/vdc_100099156604.0x00003c